188
Views
0
CrossRef citations to date
0
Altmetric
Articles

Assessing the Risk of Prostate Cancer with Nutritional and Environmental Factors: A Cross-Sectional Study from National Health and Nutrition Examination Survey 2001–2010

& ORCID Icon
Pages 1361-1372 | Received 11 Jan 2023, Accepted 27 Mar 2023, Published online: 10 Apr 2023

References

  • Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708.
  • Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control. 2008;19(2):175–81. doi:10.1007/s10552-007-9083-8.
  • Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA. 1998;279(19):1542–7. doi:10.1001/jama.279.19.1542
  • Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst. 2013;105(17):1292–7. doi:10.1093/jnci/djt169.
  • Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer. 2006;106(2):320–8. doi:10.1002/cncr.21603
  • Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, Agoritsas T, Dahm P. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519. doi:10.1136/bmj.k3519.
  • Wei C, Tian L, Jia B, Wang M, Xiong M, Hu B, Deng C, Hou Y, Hou T, Yang X, et al. Association between serum triglycerides and prostate specific antigen (PSA) among U.S. males: National Health and Nutrition Examination Survey (NHANES), 2003–2010. Nutrients. 2022;14(7):1325. doi:10.3390/nu14071325.
  • Slade AN. Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment. J Cancer Surviv. 2019;13(2):171–9. doi:10.1007/s11764-019-00739-z.
  • McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E. Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001–2008 National Health and Nutrition Examination Survey. Prostate. 2014;74(5):561–7. doi:10.1002/pros.22782.
  • Wu H, Wang M, Raman JD, McDonald AC. Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States. PLoS One. 2021;16(4):e0250744. doi:10.1371/journal.pone.0250744.
  • Lewis JE, Soler-Vilá H, Clark PE, Kresty LA, Allen GO, Hu JJ. Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer. 2009;61(2):216–24. doi:10.1080/01635580802419756.
  • McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020;12(9):2652. doi:10.3390/nu12092652.
  • Liu C-L, Soong R-S, Lee W-C, Jiang G-W, Lin Y-C. Predicting short-term survival after liver transplantation using machine learning. Sci Rep. 2020;10(1):5654. doi:10.1038/s41598-020-62387-z.
  • Kavakiotis I, Tsave O, Salifoglou A, Maglaveras N, Vlahavas I, Chouvarda I. Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J. 2017;15:104–16. doi:10.1016/j.csbj.2016.12.005.
  • Mo X, Chen X, Li H, Li J, Zeng F, Chen Y, He F, Zhang S, Li H, Pan L, et al. Early and accurate prediction of clinical response to methotrexate treatment in juvenile idiopathic arthritis using machine learning. Front Pharmacol. 2019;10:1155. doi:10.3389/fphar.2019.01155.
  • Wei H, Sun J, Shan W, Xiao W, Wang B, Ma X, Hu W, Wang X, Xia Y. Environmental chemical exposure dynamics and machine learning-based prediction of diabetes mellitus. Sci Total Environ. 2022;806(Pt 2):150674. doi:10.1016/j.scitotenv.2021.150674.
  • Zhang C, Chen X, Wang S, Hu J, Wang C, Liu X. Using CatBoost algorithm to identify middle-aged and elderly depression, national health and nutrition examination survey 2011–2018. Psychiatry Res. 2021;306:114261. doi:10.1016/j.psychres.2021.114261.
  • De Silva K, Jönsson D, Demmer RT. A combined strategy of feature selection and machine learning to identify predictors of prediabetes. J Am Med Inform Assoc. 2020;27(3):396–406. doi:10.1093/jamia/ocz204.
  • Wang S, Ji Y, Chen Y, Du P, Cao Y, Yang X, Ma J, Yu Z, Yang Y. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in the localized prostate cancer and benign prostate hyperplasia: a retrospective clinical study. Front Oncol. 2021;11:812319. doi:10.3389/fonc.2021.812319.
  • Cordeiro L, Silva TH, de Oliveira LC, Neto JFN. Systemic inflammation and nutritional status in patients on palliative cancer care: a systematic review of observational studies. Am J Hosp Palliat Care. 2020;37(7):565–71. doi:10.1177/1049909119886833.
  • Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, Bohn T. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562. doi:10.3390/nu12061562.
  • Xu B, Liu Z, Zhao J, Yu Z. Selenium intake help prevent age-related cataract formation: evidence from NHANES 2001–2008. Front Nutr. 2023;10:1042893. doi:10.3389/fnut.2023.1042893.
  • Saydah S, Bullard KM, Cheng Y, Ali MK, Gregg EW, Geiss L, Imperatore G. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999–2010. Obesity (Silver Spring). 2014;22(8):1888–95. doi:10.1002/oby.20761.
  • Yerukala Sathipati S, Tsai M-J, Shukla SK, Ho S-Y, Liu Y, Beheshti A. Author correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. Sci Rep. 2022;12(1):4990. doi:10.1038/s41598-022-09235-4.
  • Zhou Y, Romijnders R, Hansen C, Campen Jv, Maetzler W, Hortobágyi T, Lamoth CJC. The detection of age groups by dynamic gait outcomes using machine learning approaches. Sci Rep. 2020;10(1):4426. doi:10.1038/s41598-020-61423-2.
  • Dols JAM, Molenaar D, van der Helm JJ, Caspers MPM, de Kat Angelino-Bart A, Schuren FHJ, Speksnijder AGCL, Westerhoff HV, Richardus JH, Boon ME, et al. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity. BMC Infect Dis. 2016;16:180. doi:10.1186/s12879-016-1513-3.
  • Chen Z, Yang X, Bi G, Liang J, Hu Z, Zhao M, Li M, Lu T, Zheng Y, Sui Q, et al. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma. Int J Biol Sci. 2020;16(12):2205–19. doi:10.7150/ijbs.42080.
  • Zhang B, Zhang Y, Jiang X. Feature selection for global tropospheric ozone prediction based on the BO-XGBoost-RFE algorithm. Sci Rep. 2022;12(1):9244. doi:10.1038/s41598-022-13498-2.
  • Burnell SEA, Spencer-Harty S, Howarth S, Bodger O, Kynaston H, Morgan C, Doak SH. Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer. PLoS One. 2019;14(8):e0220456. doi:10.1371/journal.pone.0220456.
  • Siegel DA, O’Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race/ethnicity - United States, 2001–2017. MMWR Morb Mortal Wkly Rep. 2020;69(41):1473–80. doi:10.15585/mmwr.mm6941a1.
  • Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273(7):548–52.
  • Velonas VM, Woo HH, dos Remedios CG, Assinder SJ. Current status of biomarkers for prostate cancer. Int J Mol Sci. 2013;14(6):11034–60. doi:10.3390/ijms140611034.
  • Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis. Eur Urol. 2005;48(3):386–99. doi:10.1016/j.eururo.2005.04.015
  • Loprinzi PD, Kohli M. Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003–2006. Mayo Clin Proc. 2013;88(1):11–21. doi:10.1016/j.mayocp.2012.10.012.
  • Ho DSW, Schierding W, Wake M, Saffery R, O’Sullivan J. Machine learning SNP based prediction for precision medicine. Front Genet. 2019;10:267. doi:10.3389/fgene.2019.00267.
  • Newton R, Wernisch L. A comparison of machine learning and Bayesian modelling for molecular serotyping. BMC Genomics. 2017;18(1):606. doi:10.1186/s12864-017-3998-6.
  • Musoro JZ, Zwinderman AH, Puhan MA, ter Riet G, Geskus RB. Validation of prediction models based on lasso regression with multiply imputed data. BMC Med Res Methodol. 2014;14:116. doi:10.1186/1471-2288-14-116.
  • Bouba I, Visser B, Kemp B, Rodenburg TB, van den Brand H. Predicting hatchability of layer breeders and identifying effects of animal related and environmental factors. Poult Sci. 2021;100(10):101394. doi:10.1016/j.psj.2021.101394.
  • Zhang Y, Chen J, Wang Y, Wang D, Cong W, Lai BS, Zhao Y. Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients. PLoS One. 2019;14(4):e0202311. doi:10.1371/journal.pone.0202311.
  • Watts EL, Perez-Cornago A, Kothari J, Allen NE, Travis RC, Key TJ. Hematologic markers and prostate cancer risk: a prospective analysis in UK Biobank. Cancer Epidemiol Biomarkers Prev. 2020;29(8):1615–26. doi:10.1158/1055-9965.EPI-19-1525.
  • Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166(13):1380–8. doi:10.1001/archinte.166.13.1380
  • Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, Beaumont RN, Wittemans L, Martin S, Busch AS, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252–8. doi:10.1038/s41591-020-0751-5.
  • YuPeng L, YuXue Z, PengFei L, Cheng C, YaShuang Z, DaPeng L, Chen D. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1086–93. doi:10.1158/1055-9965.EPI-14-1329.
  • Garrido MM, Marta JC, Ribeiro RM, Pinheiro LC, Guimarães JT. Serum lipids and prostate cancer. J Clin Lab Anal. 2021;35(4):e23705. doi:10.1002/jcla.23705.
  • Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12(6):751–9. doi:10.1016/j.coph.2012.07.006.
  • Škara L, Huđek Turković A, Pezelj I, Vrtarić A, Sinčić N, Krušlin B, Ulamec M. Prostate cancer-focus on cholesterol. Cancers. 2021;13(18):4696. doi:10.3390/cancers13184696.
  • Guzel S, Kiziler L, Aydemir B, Alici B, Ataus S, Aksu A, Durak H. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma. Biol Trace Elem Res. 2012;145(1):23–32. doi:10.1007/s12011-011-9162-2.
  • Mezynska M, Brzóska MM. Environmental exposure to cadmium-a risk for health of the general population in industrialized countries and preventive strategies. Environ Sci Pollut Res Int. 2018;25(4):3211–32. doi:10.1007/s11356-017-0827-z.
  • Siddiqui MKJ, Srivastava S, Mehrotra PK. Environmental exposure to lead as a risk for prostate cancer. Biomed Environ Sci. 2002;15(4):298–305.
  • Li B, Lu Z, Wang S, Hou J, Xia G, Li H, Yin B, Lu W. Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer. BMC Cancer. 2020;20(1):361. doi:10.1186/s12885-020-06879-1.
  • Shu K, Zheng Y, Chen J, Li W, Jiang K. Prognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy. Onco Targets Ther. 2018;11:4551–8. doi:10.2147/OTT.S151314.
  • Fan L, Wang X, Chi C, Wang Y, Cai W, Shao X, Xu F, Pan J, Zhu Y, Shangguan X, et al. Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone. Prostate. 2017;77(12):1233–41. doi:10.1002/pros.23381.
  • Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. doi:10.1038/nature07205.
  • Ghoshal A, Garmo H, Arthur R, Carroll P, Holmberg L, Hammar N, Jungner I, Malmström H, Lambe M, Walldius G, et al. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum. Oncotarget. 2018;9(1):774–82. doi:10.18632/oncotarget.22891.
  • Gururajan M, Posadas EM, Chung LWK. Future perspectives of prostate cancer therapy. Transl Androl Urol. 2012;1:19–32. doi:10.3978/j.issn.2223-4683.2012.01.03.
  • Ding R, Chen Z, He M, Cen H, Liu Z, Su Y. Application value of combined detection of NLR, PNI, D-dimer, CD3 T lymphocytes, and CEA in colorectal cancer screening. Dis Markers. 2022;2022:7913025. doi:10.1155/2022/7913025.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.